North America Latin America Infusion Pump Market Size & Share Analysis - Growth Trends and Forecast (2026 - 2035)
North America Latin America Infusion Pump Market: by Type (Volumetric Infusion Pumps, Syringe Infusion Pumps, Patient-Controlled Analgesia (PCA) Pumps, Insulin Pumps, Enteral Pumps, Ambulatory Infusion Pumps), Application (Chemotherapy, Diabetes Management, Gastroenterology, Pain Management, Pediatrics/Neonatology, Others), Distribution Channels (Direct Tenders, Retail Sales, Online Sales, Distributors, Hospital Pharmacies, Others), Technology (Traditional Infusion Pumps, Specialty Infusion Pumps, Smart Infusion Pumps, Elastomeric Infusion Pumps, Implantable Infusion Pumps, Disposable Infusion Pumps), Organization Size (Small, Medium, Large) and By North America Historical & Forecast Period (2020-2035) Comprehensive Study 2025
Last Updated: 31-07-2025 | Format: PDF | Report ID:20431
North America Latin America Infusion Pump Market Analysis (2025-2035)
The infusion pump market across North and Latin America is set for substantial growth, driven by innovation in healthcare technology and increasing prevalence of chronic diseases. Key market trends include the adoption of smart infusion pumps, integration of wireless connectivity, and the push for patient safety measures. With robust competition from leading manufacturers and expanding usage in hospitals, ambulatory settings, and home care, the market is poised for strong revenue growth through 2035. Increasing investments in digital health infrastructure and rising demand for advanced drug delivery systems further propel market expansion.
Latest Market Dynamics
Key Drivers
Growing prevalence of chronic diseases such as diabetes and cancer, necessitating continuous infusion therapies, is a primary growth factor. For example, Medtronic plc recently expanded its insulin pump product line across the Americas with advanced features aimed at better glycemic control.
Technological advancements, such as the integration of smart infusion pumps with electronic health records, are enhancing medication safety and supporting adoption. Becton, Dickinson and Company (BD) introduced next-generation smart pumps in June 2024, increasing clinical efficacy and streamlining workflow for medical staff.
Key Trends
Rapid adoption of wireless and cloud-connected infusion pumps, allowing for remote monitoring and proactive troubleshooting. ICU Medical, Inc. launched a new connected infusion solution this year, enabling real-time data analytics for better patient care.
Increasing focus on ambulatory care and home infusion therapies, driven by patient preference and healthcare system cost containment. Insulet Corporation launched a portable insulin patch pump platform in recently, targeting home-based diabetes management.
Key Opportunities
Expansion in Latin American healthcare markets due to government investment and healthcare infrastructure development, providing vast opportunities for market penetration. Baxter International Inc. announced partnerships with local hospitals in Mexico in July 2024 to accelerate pump adoption.
Shift to value-based care prompting hospitals and clinics to prioritize efficient, error-reducing infusion technologies. Fresenius Kabi AG’s investment into AI-enabled infusion solutions in June 2024 positions the company to tap new growth avenues.
Key Challenges
Stringent regulatory landscape delaying market entry for innovative devices remains a challenge, as seen by delays in Smiths Medical securing approvals for their latest infusion system in select LATAM countries.
Limited skilled workforce for advanced infusion management in emerging Latin American economies, impacting uptake. Mindray Medical International has initiated local training programs to address this issue in 2024.
Key Restraints
High capital costs associated with advanced smart infusion pumps limit migration, particularly in cost-sensitive markets. Smaller clinics in rural Mexico report inability to upgrade systems post-2024 despite government subsidies.
Risk of cybersecurity breaches with connected infusion devices, deterring widespread acceptance. Roche Diagnostics highlighted ongoing security enhancement efforts after IT threat incidents in May 2024.
Market Share by Type (2025)
In 2025, volumetric infusion pumps are projected to hold the largest share of the North America Latin America Infusion Pump Market, followed by syringe infusion pumps and insulin pumps. The wide adoption of volumetric pumps is attributed to their versatility in precise drug and fluid delivery for various clinical applications. Syringe pumps are preferred in critical care and neonatal units for their accuracy, while insulin pumps maintain a strong foothold due to surging diabetes prevalence. Innovation and integration of wireless capabilities are catalyzing uptake across all segments, as providers prioritize enhanced patient safety and workflow optimization. This diverse market composition reflects the rapid technological advancements and changing therapy demands within clinical, homecare, and ambulatory settings.
Market Share by Applications (2025)
Chemotherapy remains the dominant application in the infusion pump market for North America and Latin America in 2025, holding the highest percentage share. This leadership is due to the continuously rising cancer incidence and preference for controlled drug delivery in oncology. Diabetes management is the second largest contributor, driven by growing adoption of insulin pumps in outpatient and homecare settings—especially amid rising chronic disease rates. Pain management applications account for a significant market share as well, with demand fueled by increased elective surgeries, aging populations, and advancements in PCA pump technologies. Together, these three applications represent the bulk of the market, highlighting the infusion pump’s critical role in both long-term disease management and acute care scenarios.
Market Revenue (2020-2035)
The North America Latin America Infusion Pump Market is forecast to achieve robust growth from 2020 to 2035, reflecting expanding demand for advanced drug delivery solutions. In 2025, market revenue is expected to exceed $3,250 Million, up from $2,600 Million in 2020. Steady adoption across hospitals, ambulatory settings, and homecare drives progress, accelerated by technological advancements and growing investment in digital health infrastructures. Notably, the revenue surge is projected to continue through 2035, reaching around $6,800 Million as chronic disease rates increase and healthcare systems modernize. Strategic collaborations among medical device players and governments underpin this long-term momentum, with ongoing innovation ensuring sustained value creation for providers and patients.
Market YOY Growth (2020-2035)
Year-over-year (YOY) growth rates in the North America Latin America Infusion Pump Market are consistently positive, starting at 4.2% in 2021 and peaking at 7.5% in 2030. The average annual growth for the segment is anticipated at 5.9% over the forecast period, reflecting continuous product innovations and broader patient outreach. Surges are notably observed post-pandemic due to increased healthcare infrastructure spending, digital health adoption, and focus on chronic disease management. While growth moderates slightly after 2030 as markets mature, the persistent entry of smart and connected devices maintains robust expansion, ensuring the sector’s resilience and adaptability through 2035.
Market Share by Regions (2025)
In 2025, the United States dominates the North America Latin America Infusion Pump Market with the largest regional share, propelled by high healthcare expenditure, rapid adoption of smart medical devices, and extensive hospital networks. Mexico holds the second spot, buoyed by supportive healthcare reforms and expanding access to advanced therapies. Canada completes the top three, leveraging strong public healthcare systems and increasing investment in digital health tools. These three countries account for a combined market share in excess of 80%, illustrating the substantial regional income disparities and differences in healthcare accessibility. Both innovation and infrastructure investment remain key themes shaping the regional makeup of the sector.
Market Players Share (2025)
By 2025, the market is characterized by a moderate-to-high level of concentration, with leading global players capturing the lion’s share through continuous innovation, partnerships, and extensive distribution channels. Becton, Dickinson and Company leads at 21%, leveraging its integrated platform solutions and robust R&D investments. Baxter International Inc. and ICU Medical, Inc. follow, focusing on smart infusion technologies and specialty products. The remaining market is split between regional specialists and new entrants investing heavily in competitive differentiation. This landscape demonstrates the importance of scale, reliability, and advanced features as core differentiators for sustained market leadership.
Market Buyers Share (2025)
Hospital pharmacies continue to represent the largest buyer segment within the North America Latin America Infusion Pump Market in 2025, wielding significant purchasing power due to volume orders and centralized buying systems. Outpatient clinics and home healthcare providers are experiencing growing shares, driven by the shift toward ambulatory and remote care management. E-commerce channels are also gaining traction, enabling easier procurement and wider access to advanced devices. This evolving dynamic places greater emphasis on value-based offerings, customer support, and post-sale service as key criteria in hospital and clinical purchasing decisions.
Study Coverage
Metrics
Details
Years
2020-2035
Base Year
2025
Market Size
3250
Regions
North America, Latin America, United States, Mexico, Canada
Segments
By Type, By Application, By Distribution Channels, By Technology, By Organization Size
Players
Becton, Dickinson and Company, Baxter International Inc., ICU Medical, Inc., Fresenius Kabi AG, Smiths Medical, Terumo Corporation, Medtronic plc, Braun Melsungen AG, Mindray Medical International Limited, Roche Diagnostics, Moog Inc., Tandem Diabetes Care, Inc., Insulet Corporation, Avanos Medical, Inc., Nipro Corporation
Key Recent Developments
June 2024: Becton, Dickinson and Company launched its next-generation wireless smart infusion pump series with enhanced connectivity and user-focused safety features.
July 2024: Baxter International Inc. signed a multi-year partnership with Mexico’s leading public healthcare providers to expand infusion pump access in major hospitals.
August 2024: Fresenius Kabi AG secured CE Mark approval for its new AI-powered infusion system, supporting early adoption in pilot Canadian clinics.
June 2024: Mindray Medical International initiated advanced workforce training programs in Brazil and Mexico to accelerate skilled adoption of complex infusion pump systems.
September 2024: Smiths Medical announced regulatory clearance of their portable ambulatory infusion pump across the United States and select LATAM markets.
